Lumos Pharma, Inc. (LUMO) Financials
LUMO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 40.6 million | 13.3 million |
2023-09-30 | 47.8 million | 12.3 million |
2023-06-30 | 56.4 million | 12.7 million |
2023-03-31 | 63.7 million | 11.2 million |
LUMO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -7.4 million | 524000 |
2023-09-30 | -1.4 million | 559000 |
2023-06-30 | -10.6 million | 653000 |
2023-03-31 | -11.7 million | 586000 |
LUMO Net Income
No data available :(
LUMO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 36.1 million | - | 585000 |
2023-09-30 | 42.7 million | - | 269000 |
2023-06-30 | 50.9 million | - | 346000 |
2023-03-31 | 58.0 million | - | 421000 |
LUMO Shares Outstanding
LUMO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 6.7 million | 4.2 million | 18000 |
2023-09-30 | 6.4 million | 5.0 million | 3.9 million | - |
2023-06-30 | 3.9 million | 6.0 million | 4.1 million | - |
2023-03-31 | 2.5 million | 4.4 million | 4.4 million | - |
LUMO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 826000 | 18000 |
2023-09-30 | 7000 | 8000 |
2023-06-30 | 527000 | 9000 |
2023-03-31 | 691000 | 9000 |
LUMO
Price: $2.81
52 week price:
Earnings Per Share: -4.18 USD
P/E Ratio: -0.76
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 22134
Market Capitalization: 21.4 million